Is Tenaya Therapeutics, Inc. (TNYA) a Buy, Sell, or Hold?
Tenaya Therapeutics, Inc.
NASDAQ:TNYA
$0.8432 USD
-$0.02 (-2.48%)
- Volume
- 1.81M
- Average Volume
- 3.75M
- Market Capitalization
- $140.48M
- P/E Ratio
- -1.79
- Dividend Yield
- 0.00%
- Price Target
- $2.00
- Year High
- $2.35
- Year Low
- $0.53
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $5.75
NUMBER OF INSIDERS BUYING (LAST 12 MONTHS)
14
NUMBER OF INSIDERS SELLING (LAST 12 MONTHS)
26
AMOUNT OF INSIDER SELLING (LAST 12 MONTHS)
$ 7.79M
TNYA Estimated and Actual Revenue by Quarter
Get MSFT Insider Trade Alerts
TNYA Insider Trading History
| Insider Name | Title | Date | Transaction | Cost | Filing Date |
|---|---|---|---|---|---|
| Hyllengren Eric J | 2026-07-13 | 0 | 2026-07-14 | ||
| Hyllengren Eric J | officer: Chief Financial Officer | 2026-07-13 | A-Award | 0.8365 | 2026-07-14 |
| Williams R Sanders | director | 2026-05-28 | A-Award | 0.7989 | 2026-05-29 |
| Walsh Jeffrey T. | director | 2026-05-28 | A-Award | 0.7989 | 2026-05-29 |
| Stehman-Breen Catherine | director | 2026-05-28 | A-Award | 0.7989 | 2026-05-29 |
| Srivastava Deepak | director | 2026-05-28 | A-Award | 0.7989 | 2026-05-29 |
| Parschauer Karah Herdman | director | 2026-05-28 | A-Award | 0.7989 | 2026-05-29 |
| Lee June | director | 2026-05-28 | A-Award | 0.7989 | 2026-05-29 |
| Burroughs Amy L. | director | 2026-05-28 | A-Award | 0.7989 | 2026-05-29 |
| Ali Faraz | director, officer: Chief Executive Officer | 2026-05-18 | S-Sale | 0.7934 | 2026-05-19 |
| Tingley Whittemore | officer: Chief Medical Officer | 2026-05-18 | S-Sale | 0.7936 | 2026-05-19 |
| Higa Tomohiro | officer: SVP, Finance | 2026-05-18 | S-Sale | 0.7932 | 2026-05-19 |
| COLUMN GROUP III GP, LP | 10 percent owner | 2026-02-24 | S-Sale | 0.6153 | 2026-02-26 |
| COLUMN GROUP III GP, LP | 10 percent owner | 2026-02-24 | S-Sale | 0.6153 | 2026-02-26 |
| COLUMN GROUP III GP, LP | 10 percent owner | 2026-02-25 | S-Sale | 0.5624 | 2026-02-26 |
| COLUMN GROUP III GP, LP | 10 percent owner | 2026-02-20 | S-Sale | 0.6149 | 2026-02-24 |
| COLUMN GROUP III GP, LP | 10 percent owner | 2026-02-23 | S-Sale | 0.5972 | 2026-02-24 |
| COLUMN GROUP III GP, LP | 10 percent owner | 2026-02-20 | S-Sale | 0.6149 | 2026-02-24 |
| COLUMN GROUP III GP, LP | 10 percent owner | 2026-02-23 | S-Sale | 0.5972 | 2026-02-24 |
| Higa Tomohiro | officer: SVP, Finance | 2026-02-17 | S-Sale | 0.6434 | 2026-02-17 |
| Higa Tomohiro | officer: SVP, Finance | 2026-02-17 | S-Sale | 0.6434 | 2026-02-17 |
| Higa Tomohiro | officer: SVP, Finance | 2026-02-17 | S-Sale | 0.6431 | 2026-02-17 |
| Ali Faraz | director, officer: Chief Executive Officer | 2026-02-17 | S-Sale | 0.643 | 2026-02-17 |
| Ali Faraz | director, officer: Chief Executive Officer | 2026-02-17 | S-Sale | 0.6431 | 2026-02-17 |
| Ali Faraz | director, officer: Chief Executive Officer | 2026-02-17 | S-Sale | 0.643 | 2026-02-17 |
| Tingley Whittemore | officer: Chief Medical Officer | 2026-02-17 | S-Sale | 0.6432 | 2026-02-17 |
| Tingley Whittemore | officer: Chief Medical Officer | 2026-02-17 | S-Sale | 0.6432 | 2026-02-17 |
| Tingley Whittemore | officer: Chief Medical Officer | 2026-02-17 | S-Sale | 0.6431 | 2026-02-17 |
| COLUMN GROUP III GP, LP | 10 percent owner | 2026-02-10 | S-Sale | 0.8161 | 2026-02-12 |
| COLUMN GROUP III GP, LP | 10 percent owner | 2026-02-10 | S-Sale | 0.8161 | 2026-02-12 |
| COLUMN GROUP III GP, LP | 10 percent owner | 2026-02-11 | S-Sale | 0.6808 | 2026-02-12 |
| COLUMN GROUP III GP, LP | 10 percent owner | 2026-02-11 | S-Sale | 0.6808 | 2026-02-12 |
| Higa Tomohiro | officer: SVP, Finance | 2026-02-03 | A-Award | 0.915 | 2026-02-05 |
| Higa Tomohiro | officer: SVP, Finance | 2026-02-03 | A-Award | 0 | 2026-02-05 |
| Tingley Whittemore | officer: Chief Medical Officer | 2026-02-03 | A-Award | 0.915 | 2026-02-05 |
| Tingley Whittemore | officer: Chief Medical Officer | 2026-02-03 | A-Award | 0 | 2026-02-05 |
| Ali Faraz | director, officer: Chief Executive Officer | 2026-02-03 | A-Award | 0.915 | 2026-02-05 |
| Ali Faraz | director, officer: Chief Executive Officer | 2026-02-03 | A-Award | 0 | 2026-02-05 |
| Higa Tomohiro | officer: SVP, Finance | 2025-11-17 | S-Sale | 1.33 | 2025-11-17 |
| Tingley Whittemore | officer: Chief Medical Officer | 2025-11-17 | S-Sale | 1.33 | 2025-11-17 |
| Ali Faraz | director, officer: Chief Executive Officer | 2025-11-17 | S-Sale | 1.33 | 2025-11-17 |
| Higa Tomohiro | officer: SVP, Finance | 2025-08-18 | S-Sale | 1.253 | 2025-08-18 |
| Higa Tomohiro | officer: SVP, Finance | 2025-08-18 | S-Sale | 1.253 | 2025-08-18 |
| Higa Tomohiro | officer: SVP, Finance | 2025-08-18 | S-Sale | 1.253 | 2025-08-18 |
| Tingley Whittemore | officer: Chief Medical Officer | 2025-08-18 | S-Sale | 1.253 | 2025-08-18 |
| Tingley Whittemore | officer: Chief Medical Officer | 2025-08-18 | S-Sale | 1.253 | 2025-08-18 |
| Tingley Whittemore | officer: Chief Medical Officer | 2025-08-18 | S-Sale | 1.253 | 2025-08-18 |
| Ali Faraz | director, officer: Chief Executive Officer | 2025-08-18 | S-Sale | 1.253 | 2025-08-18 |
| Ali Faraz | director, officer: Chief Executive Officer | 2025-08-18 | S-Sale | 1.253 | 2025-08-18 |
| Ali Faraz | director, officer: Chief Executive Officer | 2025-08-18 | S-Sale | 1.253 | 2025-08-18 |
| Stehman-Breen Catherine | director | 2025-05-29 | A-Award | 0.4444 | 2025-05-30 |
| Walsh Jeffrey T. | director | 2025-05-29 | A-Award | 0.4444 | 2025-05-30 |
| Burroughs Amy L. | director | 2025-05-29 | A-Award | 0.4444 | 2025-05-30 |
| GOEDDEL DAVID V | director, 10 percent owner: | 2025-05-29 | A-Award | 0.4444 | 2025-05-30 |
| Williams R Sanders | director | 2025-05-29 | A-Award | 0.4444 | 2025-05-30 |
| Srivastava Deepak | director | 2025-05-29 | A-Award | 0.4444 | 2025-05-30 |
| Lee June | director | 2025-05-29 | A-Award | 0.4444 | 2025-05-30 |
| Parschauer Karah Herdman | director | 2025-05-29 | A-Award | 0.4444 | 2025-05-30 |
| Higa Tomohiro | officer: SVP, Finance | 2025-05-16 | S-Sale | 0.4427 | 2025-05-16 |
| Tingley Whittemore | officer: Chief Medical Officer | 2025-05-16 | S-Sale | 0.4427 | 2025-05-16 |
| Ali Faraz | director, officer: Chief Executive Officer | 2025-05-16 | S-Sale | 0.4427 | 2025-05-16 |
| Higa Tomohiro | officer: SVP, Finance | 2025-03-10 | S-Sale | 0.5384 | 2025-03-10 |
| Higa Tomohiro | officer: SVP, Finance | 2025-03-10 | S-Sale | 0.5384 | 2025-03-10 |
| Higa Tomohiro | officer: SVP, Finance | 2025-03-10 | S-Sale | 0.5384 | 2025-03-10 |
| Tingley Whittemore | officer: Chief Medical Officer | 2025-03-10 | S-Sale | 0.5384 | 2025-03-10 |
| Tingley Whittemore | officer: Chief Medical Officer | 2025-03-10 | S-Sale | 0.5384 | 2025-03-10 |
| Tingley Whittemore | officer: Chief Medical Officer | 2025-03-10 | S-Sale | 0.5384 | 2025-03-10 |
| Ali Faraz | director, officer: Chief Executive Officer | 2025-03-10 | S-Sale | 0.5384 | 2025-03-10 |
| Ali Faraz | director, officer: Chief Executive Officer | 2025-03-10 | S-Sale | 0.5384 | 2025-03-10 |
| COLUMN GROUP III GP, LP | 10 percent owner | 2025-03-05 | P-Purchase | 0.7 | 2025-03-07 |
| COLUMN GROUP III GP, LP | 10 percent owner | 2025-03-05 | P-Purchase | 0.8 | 2025-03-07 |
| COLUMN GROUP III GP, LP | 10 percent owner | 2025-03-05 | P-Purchase | 0.7 | 2025-03-07 |
| GOEDDEL DAVID V | director, 10 percent owner: | 2025-03-05 | P-Purchase | 0.7 | 2025-03-07 |
| GOEDDEL DAVID V | director, 10 percent owner: | 2025-03-05 | P-Purchase | 0.8 | 2025-03-07 |
| GOEDDEL DAVID V | director, 10 percent owner: | 2025-03-05 | P-Purchase | 0.7 | 2025-03-07 |
| Higa Tomohiro | officer: SVP, Finance | 2025-02-06 | 0 | 2025-02-07 | |
| Higa Tomohiro | officer: SVP, Finance | 2025-02-06 | 0 | 2025-02-07 | |
| Higa Tomohiro | officer: SVP, Finance | 2025-02-24 | 1.21 | 2025-02-07 | |
| Higa Tomohiro | officer: SVP, Finance | 2021-03-10 | 2.7 | 2025-02-07 | |
| Ali Faraz | director, officer: Chief Executive Officer | 2025-02-06 | A-Award | 1 | 2025-02-07 |
| Ali Faraz | director, officer: Chief Executive Officer | 2025-02-06 | A-Award | 1.21 | 2025-02-07 |
| Ali Faraz | director, officer: Chief Executive Officer | 2025-02-06 | A-Award | 1.21 | 2025-02-07 |
| Ali Faraz | director, officer: Chief Executive Officer | 2025-02-06 | A-Award | 0 | 2025-02-07 |
| Ali Faraz | director, officer: Chief Executive Officer | 2025-02-06 | A-Award | 0 | 2025-02-07 |
| Ali Faraz | director, officer: Chief Executive Officer | 2025-02-06 | A-Award | 1.21 | 2025-02-07 |
| Ali Faraz | director, officer: Chief Executive Officer | 2025-02-06 | D-Return | 5.64 | 2025-02-07 |
| Ali Faraz | director, officer: Chief Executive Officer | 2025-02-06 | D-Return | 9.36 | 2025-02-07 |
| Ali Faraz | director, officer: Chief Executive Officer | 2025-02-06 | D-Return | 15.19 | 2025-02-07 |
| Tingley Whittemore | officer: Chief Medical Officer | 2025-01-24 | A-Award | 1.21 | 2025-01-28 |
| Tingley Whittemore | officer: Chief Medical Officer | 2025-01-24 | A-Award | 1.21 | 2025-01-28 |
| Tingley Whittemore | officer: Chief Medical Officer | 2025-01-24 | A-Award | 1.21 | 2025-01-28 |
| Tingley Whittemore | officer: Chief Medical Officer | 2025-01-24 | A-Award | 0 | 2025-01-28 |
| Tingley Whittemore | officer: Chief Medical Officer | 2025-01-24 | A-Award | 0 | 2025-01-28 |
| Tingley Whittemore | officer: Chief Medical Officer | 2025-01-24 | A-Award | 1.21 | 2025-01-28 |
| Tingley Whittemore | officer: Chief Medical Officer | 2025-01-24 | A-Award | 1.21 | 2025-01-28 |
| Tingley Whittemore | officer: Chief Medical Officer | 2025-01-24 | D-Return | 5.22 | 2025-01-28 |
| Tingley Whittemore | officer: Chief Medical Officer | 2025-01-24 | D-Return | 15.19 | 2025-01-28 |
| Tingley Whittemore | officer: Chief Medical Officer | 2025-01-24 | D-Return | 9.36 | 2025-01-28 |
| Tingley Whittemore | officer: Chief Medical Officer | 2025-01-24 | D-Return | 3.06 | 2025-01-28 |
| Saito Chihiro | officer: SVP, Accounting and Fin. Ops. | 2024-11-18 | S-Sale | 2.12 | 2024-11-18 |